
Reconil200 mg
Incepta Pharmaceuticals Ltd.
Hydroxychloroquine Sulphate is a 4-aminoquinoline antimalarial and disease-modifying antirheumatic drug (DMARD) with the following indications: Established / FDA-approved uses Malaria: Treatment of…
Hydroxychloroquine Sulphate is a 4-aminoquinoline antimalarial and disease-modifying antirheumatic drug (DMARD) with the following indications:
Note: Hydroxychloroquine Sulphate does not have proven efficacy for the treatment or prevention of COVID-19; use for this purpose is not supported by current evidence and is not recommended.
Dosage of Hydroxychloroquine Sulphate is individualized by indication, body weight and clinical response. The following is a general guide; the treating physician's prescription should always be followed.
| Indication | Adult dose | Notes |
|---|---|---|
| Malaria treatment (adult) | 800 mg salt initially, then 400 mg at 6 hours, 400 mg at 24 hours, and 400 mg at 48 hours (total 2000 mg salt over 3 days) | Confirm local resistance patterns; combination therapy may be required in some regions |
| Malaria prophylaxis (adult) | 400 mg salt once weekly, starting 1-2 weeks before travel, continued weekly during exposure and for 4 weeks after leaving the endemic area | Only for areas without chloroquine resistance |
| Rheumatoid arthritis | Initially 400-600 mg/day in divided doses; maintenance 200-400 mg/day once optimal response achieved | Usually combined with other DMARDs; reassess after 3-6 months if no benefit |
| Lupus erythematosus (SLE/DLE) | 200-400 mg/day (up to 400-600 mg/day initially in some regimens), given once daily or in divided doses | Long-term maintenance often continued at the lowest effective dose |
For malaria in children, dosing is calculated on a mg/kg body-weight basis under direct physician supervision; hydroxychloroquine sulfate is not recommended for long-term therapy in children (see Use in Special Populations).
No well-established formal dose-adjustment schedule exists; however, Hydroxychloroquine Sulphate should be used with caution and at the lowest effective dose in patients with significant renal or hepatic impairment, with closer clinical monitoring.
Take Hydroxychloroquine Sulphate exactly as prescribed by your physician; do not stop, extend, skip doses, or share this medicine with others without medical advice.
Common and serious side effects of Hydroxychloroquine Sulphate include:
Seek prompt medical attention for visual changes, palpitations, unusual bruising/bleeding, or profound muscle weakness while taking Hydroxychloroquine Sulphate.
Hydroxychloroquine Sulphate is contraindicated in:
Long-term use of Hydroxychloroquine Sulphate in children is not recommended (short-term use for malaria treatment/prophylaxis under medical supervision is not included in this restriction).
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.